| Sharay T North, | |
|
3452 Pascagoula St Ste 2, Pascagoula, MS 39567-3203 | |
| (228) 249-9449 | |
| Not Available |
| Full Name | Sharay T North |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 3452 Pascagoula St Ste 2, Pascagoula, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366105751 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 232075 (Mississippi) | Primary |
| Provider Name | Speakeasy Clinic |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1649933250 PECOS PAC ID: 5092105858 Enrollment ID: O20211209001799 |
News Archive
The Visiting Nurse Association of Greater Philadelphia has received a grant award from the First Hospital Foundation in the amount of $40,000. The grant will be used to enhance the VNA's Wound Care Program and will enable the agency to purchase digital cameras so the home visiting clinicians can document patients wound progression and improve wound care delivery.
A yellowfin tuna product used to make dishes like sushi, ceviche and sashimi sold at restaurants and grocery stores has been connected with with an outbreak of salmonella that has sickened more than 100 people in 20 states and the District of Columbia, federal health authorities announced last Friday.
Itamar Medical, the leader in non-invasive vascular health diagnostics, announced today that an agreement has been signed with Roche by which Itamar will develop an EndoPAT device designated for use with animal models, enabling pre-clinical studies examining the efficacy of various compounds in the early stage of drug development essential for later stage development in humans.
When an antibiotic is consumed, researchers have learned that up to 90 percent passes through a body without metabolizing. This means the drugs can leave the body almost intact through normal bodily functions.
Recently, the potential of PPAR-γ as a target for the prevention and treatment of cancer has been widely studied. However, the potential therapeutic role of PPAR-γ agonists has been questioned, based on contradictory results. Studies using animal models of colon cancer found that PPAR-γ agonists increased the development of colon tumors.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sharay T North, 1403 Lake Ave, Pascagoula, MS 39567-1626 Ph: (228) 219-4793 | Sharay T North, 3452 Pascagoula St Ste 2, Pascagoula, MS 39567-3203 Ph: (228) 249-9449 |
News Archive
The Visiting Nurse Association of Greater Philadelphia has received a grant award from the First Hospital Foundation in the amount of $40,000. The grant will be used to enhance the VNA's Wound Care Program and will enable the agency to purchase digital cameras so the home visiting clinicians can document patients wound progression and improve wound care delivery.
A yellowfin tuna product used to make dishes like sushi, ceviche and sashimi sold at restaurants and grocery stores has been connected with with an outbreak of salmonella that has sickened more than 100 people in 20 states and the District of Columbia, federal health authorities announced last Friday.
Itamar Medical, the leader in non-invasive vascular health diagnostics, announced today that an agreement has been signed with Roche by which Itamar will develop an EndoPAT device designated for use with animal models, enabling pre-clinical studies examining the efficacy of various compounds in the early stage of drug development essential for later stage development in humans.
When an antibiotic is consumed, researchers have learned that up to 90 percent passes through a body without metabolizing. This means the drugs can leave the body almost intact through normal bodily functions.
Recently, the potential of PPAR-γ as a target for the prevention and treatment of cancer has been widely studied. However, the potential therapeutic role of PPAR-γ agonists has been questioned, based on contradictory results. Studies using animal models of colon cancer found that PPAR-γ agonists increased the development of colon tumors.
› Verified 4 days ago
Lakendra Brewer, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4403 Hospital St, Pascagoula, MS 39581 Phone: 228-762-8960 Fax: 228-769-1810 | |
Terral Latady, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1403 Lake Ave, Pascagoula, MS 39567 Phone: 228-219-4793 | |
Pamela Loper, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4403 Hospital St, Pascagoula, MS 39581 Phone: 228-162-8960 Fax: 662-620-9890 | |
Shelby Alexis Parker, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2809 Denny Ave, Pascagoula, MS 39581 Phone: 228-809-5000 | |
Sandi Horn, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3452 Pascagoula St, Pascagoula, MS 39567 Phone: 228-696-7088 | |
Rebecca Varnadore, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 4211 Hospital St Ste 114, Pascagoula, MS 39581 Phone: 228-762-8960 Fax: 228-769-1810 |